novo nordisk cuts prices for its glp-1 drugs. launches Wegovy weight-loss pill in US, triggering price war | Pharmaceuticals industry Novo Nordisk Slashes Wegovy Prices
Description
The Bridge program rules say that people can use the drugs to maintain weight loss. Thats because doctors have found that if people successfully lose weight using GLP-1 medications, then stop taking the drugs, they typically gain the weight back
doi: 10.4103/0019-5359.100341 251 KobayashiMAkakiJNinomiyaKYoshikawaMMuraokaOMorikawaT OdawaraMet al
Industry activity suggests rapid development in this area [14], but clinical adoption will depend on functional benefits, safety, cost-effectiveness and regulatory guidance
Quality matters enormously with compounded peptides
doi: 10.1111/dom.13553
